These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 9696965)

  • 1. A model for the determination of carbamazepine clearance in children on mono- and polytherapy.
    Gray AL; Botha JH; Miller R
    Eur J Clin Pharmacol; 1998 Jun; 54(4):359-62. PubMed ID: 9696965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A model for estimating individualized valproate clearance values in children.
    Botha JH; Gray AL; Miller R
    J Clin Pharmacol; 1995 Oct; 35(10):1020-4. PubMed ID: 8568010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of phenobarbitone population clearance values for South African children.
    Botha JH; Gray AL; Miller R
    Eur J Clin Pharmacol; 1995; 48(5):381-3. PubMed ID: 8641326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of a drug-drug interaction on population-based phenobarbitone clearance using nonlinear mixed-effects modeling.
    Yukawa E; To H; Ohdo S; Higuchi S; Aoyama T
    Eur J Clin Pharmacol; 1998 Mar; 54(1):69-74. PubMed ID: 9591934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacoepidemiologic investigation of a clonazepam-carbamazepine interaction by mixed effect modeling using routine clinical pharmacokinetic data in Japanese patients.
    Yukawa E; Nonaka T; Yukawa M; Ohdo S; Higuchi S; Kuroda T; Goto Y
    J Clin Psychopharmacol; 2001 Dec; 21(6):588-93. PubMed ID: 11763006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population pharmacokinetics of carbamazepine in Singapore epileptic patients.
    Chan E; Lee HS; Hue SS
    Br J Clin Pharmacol; 2001 Jun; 51(6):567-76. PubMed ID: 11422016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a population pharmacokinetic model for carbamazepine based on sparse therapeutic monitoring data from pediatric patients with epilepsy.
    Carlsson KC; Hoem NO; Glauser T; Vinks AA
    Clin Ther; 2005 May; 27(5):618-26. PubMed ID: 15978311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic modeling of carbamazepine based on clinical data from Serbian epileptic patients.
    Jankovic SM; Jovanovic D; Milovanovic JR
    Methods Find Exp Clin Pharmacol; 2008 Nov; 30(9):707-13. PubMed ID: 19229380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic modeling of valproate from clinical data in Serbian epileptic patients.
    Jankovic SM; Milovanovic JR
    Methods Find Exp Clin Pharmacol; 2007 Dec; 29(10):673-9. PubMed ID: 18200330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbamazepine drug interactions: the influence of concurrent drug therapy on serum concentrations of carbamazepine and its epoxide metabolite.
    Wang RB; Liu LT; Yiu CH; Chang TY
    Zhonghua Yi Xue Za Zhi (Taipei); 1990 Apr; 45(4):222-32. PubMed ID: 2168269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population pharmacokinetics of carbamazepine in Chinese epilepsy patients.
    Jiao Z; Zhong MK; Shi XJ; Hu M; Zhang JH
    Ther Drug Monit; 2003 Jun; 25(3):279-86. PubMed ID: 12766553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors influencing carbamazepine pharmacokinetics in children and adults: population pharmacokinetic analysis.
    Milovanovic JR; Jankovic SM
    Int J Clin Pharmacol Ther; 2011 Jul; 49(7):428-36. PubMed ID: 21726493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetic model of carbamazepine derived from routine therapeutic drug monitoring data.
    Vucićević K; Miljković B; Velicković R; Pokrajac M; Mrhar A; Grabnar I
    Ther Drug Monit; 2007 Dec; 29(6):781-8. PubMed ID: 18043476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comprehensive study of the relation between serum concentrations, concentration ratios, and level/dose ratios of carbamazepine and its metabolites with age, weight, dose, and clearances in epileptic children.
    Liu H; Delgado MR
    Epilepsia; 1994; 35(6):1221-9. PubMed ID: 7988515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postinduction carbamazepine clearance in an adult psychiatric population.
    Martin ES; Crismon ML; Godley PJ
    Pharmacotherapy; 1991; 11(4):296-302. PubMed ID: 1923910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum carbamazepine concentrations in elderly patients: a case-matched pharmacokinetic evaluation based on therapeutic drug monitoring data.
    Battino D; Croci D; Rossini A; Messina S; Mamoli D; Perucca E
    Epilepsia; 2003 Jul; 44(7):923-9. PubMed ID: 12823575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Population pharmacokinetics of carbamazepine in adults with epilepsy].
    Romano-Moreno S; Medina-Rojas EL; Salas-Ortiz AL; Vargas-Morales JM; Pérez-Urizar JT; Rodríguez-Leyva I
    Rev Invest Clin; 2005; 57(1):38-48. PubMed ID: 15981957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbamazepine population pharmacokinetics in children: mixed-effect models.
    Delgado Iribarnegaray MF; Santo Bueldga D; García Sánchez MJ; Otero MJ; Falcão AC; Domínguez-Gil A
    Ther Drug Monit; 1997 Apr; 19(2):132-9. PubMed ID: 9108639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetics of steady-state carbamazepine in Egyptian epilepsy patients.
    El Desoky ES; Sabarinath SN; Hamdi MM; Bewernitz M; Derendorf H
    J Clin Pharm Ther; 2012 Jun; 37(3):352-5. PubMed ID: 21883329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbamazepine and carbamazepine-10,11-epoxide serum concentrations in epileptic children.
    Furlanut M; Montanari G; Bonin P; Casara GL
    J Pediatr; 1985 Mar; 106(3):491-5. PubMed ID: 3973787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.